5-Bromo-2-chloro-7-fluoroquinoxaline

Catalog No.: 
ACZYLS379
CAS No.: 
1881290-86-3
Molecular Formula: 
C8H3BrClFN2
Molecular Weight: 
261.48
5-Bromo-2-chloro-7-fluoroquinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$155.00In stockInquiry
250mg95%$293.00In stockInquiry
1g95%$789.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-chloro-7-fluoroquinoxaline
IUPAC Name5-bromo-2-chloro-7-fluoroquinoxaline
Molecular FormulaC8H3BrClFN2
Molecular Weight261.48
SMILESFC1=CC(Br)=C2N=CC(Cl)=NC2=C1
InChI KeyOCXQJVOIMXREOA-UHFFFAOYSA-N
Synonym5-Bromo-2-chloro-7-fluoroquinoxaline;Quinoxaline, 5-bromo-2-chloro-7-fluoro-
CAS No.1881290-86-3

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZYLS379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDMZ817 route compound structure diagram
    ACHDMZ817115440-10-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZYLS379 route product structure diagram
    ACZYLS3791881290-86-3In Stock
Inquiry

2. ACZYLS379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDMZ817 route compound structure diagram
    ACHDMZ817115440-10-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZYLS379 route product structure diagram
    ACZYLS3791881290-86-3In Stock
Inquiry

3. ACZYLS379 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZYLS379 route product structure diagram
    ACZYLS3791881290-86-3In Stock
Inquiry

Comments (0)